Avoid, High Risk
GLP-1 agonist + insulin or sulfonylureas
GLP-1 agonist + Insulin or Secretagogues (sulfonylureas)
Why this combination is flagged
Hypoglycemia risk: GLP-1 enhances glucose-dependent insulin secretion; stacking with exogenous insulin or secretagogues can drive severe lows
Reported risk level
High, per peptide research and practitioner literature catalogued on PeptideHelper.org.
Peptides involved
- Semaglutide, GLP-1 receptor agonist
- Tirzepatide, GIP/GLP-1 dual incretin agonist
- Liraglutide, GLP-1 receptor agonist
- Dulaglutide, GLP-1 receptor agonist
Safer alternatives reported in literature
If the patient is already on insulin or a sulfonylurea, the prescribing clinician typically reduces or discontinues those before initiating a GLP-1 agonist. PeptideHelper.org does not provide clinical recommendations. This is research-literature framing only.
Reported research framing only. Not a clinical recommendation. Consult a qualified clinician before any human use.
Frequently asked questions
Why is GLP-1 agonist + Insulin or Secretagogues (sulfonylureas) flagged as a combination to avoid?
Hypoglycemia risk: GLP-1 enhances glucose-dependent insulin secretion; stacking with exogenous insulin or secretagogues can drive severe lows. Reported risk level in peptide research and practitioner literature: High.
How serious is the concern with GLP-1 agonist + Insulin or Secretagogues (sulfonylureas)?
PeptideHelper.org categorises this combination as High risk based on published peptide research and practitioner literature. The mechanism: Hypoglycemia risk: GLP-1 enhances glucose-dependent insulin secretion; stacking with exogenous insulin or secretagogues can drive severe lows.
What is a safer alternative to GLP-1 agonist + Insulin or Secretagogues (sulfonylureas)?
If the patient is already on insulin or a sulfonylurea, the prescribing clinician typically reduces or discontinues those before initiating a GLP-1 agonist. PeptideHelper.org does not provide clinical recommendations. This is research-literature framing only.
Which peptides are involved in this combination?
Peptides referenced by this combination on PeptideHelper.org: Semaglutide, Tirzepatide, Liraglutide, Dulaglutide.
Open the PeptideHelper.org stack evaluator to model substitute combinations and check for class-level conflicts before any research use.
Loading interactive view…